BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Prozac
,
rs2476601
,
ZBTB7A
,
glucose metabolic process
,
Influenza
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
granzymes
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
A quarter century of granzymes.
Controversies in granzyme biology.
Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.
Intercellular communication via the endo-lysosomal system: translocation of granzymes through membra…
Increased granzyme levels in cytotoxic T lymphocytes are associated with disease severity in emergen…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Granzymes and Perforin at the Onset of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Granzyme A in Patients With E. Coli Bacteremic Urinary Tract Infections
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
64Cu-GRIP B in Patients With Advanced Genitourinary Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ